Tarsus Pharmaceuticals Inc
NASDAQ:TARS

Watchlist Manager
Tarsus Pharmaceuticals Inc Logo
Tarsus Pharmaceuticals Inc
NASDAQ:TARS
Watchlist
Price: 81.35 USD -0.43% Market Closed
Market Cap: 3.5B USD

Wall Street
Price Targets

TARS Price Targets Summary
Tarsus Pharmaceuticals Inc

Wall Street analysts forecast TARS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TARS is 86.96 USD with a low forecast of 51.51 USD and a high forecast of 105 USD.

Lowest
Price Target
51.51 USD
37% Downside
Average
Price Target
86.96 USD
7% Upside
Highest
Price Target
105 USD
29% Upside
Tarsus Pharmaceuticals Inc Competitors:
Price Targets
GUD
Knight Therapeutics Inc
32% Upside
2DT
Amneal Pharmaceuticals Inc
13% Upside
603520
Zhejiang Starry Pharmaceutical Co Ltd
52% Upside
SUPRIYA
Supriya Lifescience Ltd
16% Upside
DRREDDY
Dr Reddy's Laboratories Ltd
5% Upside
016580
Whanin Pharm Co Ltd
23% Upside
KLBF
Kalbe Farma Tbk PT
48% Upside
688321
Shenzhen Chipscreen Biosciences Co Ltd
35% Upside

Revenue
Forecast

Revenue Estimate
Tarsus Pharmaceuticals Inc

The compound annual growth rate of Tarsus Pharmaceuticals Inc's revenue for the next 4 years is 54%.

N/A
Past Growth
54%
Estimated Growth
Estimates Accuracy
4%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Tarsus Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
Tarsus Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-39%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TARS's stock price target?
Price Target
86.96 USD

According to Wall Street analysts, the average 1-year price target for TARS is 86.96 USD with a low forecast of 51.51 USD and a high forecast of 105 USD.

What is Tarsus Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
54%

The compound annual growth rate of Tarsus Pharmaceuticals Inc's revenue for the next 4 years is 54%.

Back to Top